Here are some of the key gynecologic cancer presentations to watch at ASCO 2026.

Eligible participants comprised women age 25 years or older with a diagnosis of breast or gynecologic cancers and receiving treatment at four participating hospitals. Participants were asked whether ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, which is approved by the FDA in ovarian cancer, and Jemperli for ...

In 2024, the American Cancer Society estimates that uterine cancer will surpass ovarian cancer in total estimated number of deaths in the United States. That’s partly due to the progress made in ...

As part of the CURE® Educated Patient® Gynecologic Cancers Summit, an expert explained the basics of biomarkers and the questions they raise. Patients can benefit from clinical trials in gynecologic ...